60 related articles for article (PubMed ID: 19210123)
1. Dynamic proteomics for investigating the response of individual cancer cells under drug action.
Li RX; Zeng R
Expert Rev Proteomics; 2009 Feb; 6(1):19-21. PubMed ID: 19210123
[TBL] [Abstract][Full Text] [Related]
2. Dynamic proteomics of individual cancer cells in response to a drug.
Cohen AA; Geva-Zatorsky N; Eden E; Frenkel-Morgenstern M; Issaeva I; Sigal A; Milo R; Cohen-Saidon C; Liron Y; Kam Z; Cohen L; Danon T; Perzov N; Alon U
Science; 2008 Dec; 322(5907):1511-6. PubMed ID: 19023046
[TBL] [Abstract][Full Text] [Related]
3. Dynamic proteomics in individual human cells uncovers widespread cell-cycle dependence of nuclear proteins.
Sigal A; Milo R; Cohen A; Geva-Zatorsky N; Klein Y; Alaluf I; Swerdlin N; Perzov N; Danon T; Liron Y; Raveh T; Carpenter AE; Lahav G; Alon U
Nat Methods; 2006 Jul; 3(7):525-31. PubMed ID: 16791210
[TBL] [Abstract][Full Text] [Related]
4. Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view?
Kraljevic S; Sedic M; Scott M; Gehrig P; Schlapbach R; Pavelic K
Cancer Treat Rev; 2006 Dec; 32(8):619-29. PubMed ID: 17069979
[TBL] [Abstract][Full Text] [Related]
5. Dynamic proteomics in mammalian cells: capabilities and challenges.
Milo R
Mol Biosyst; 2007 Aug; 3(8):542-6. PubMed ID: 17639129
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoproteomic approach to the study of drug mode of action, toxicity, and resistance: applications in diabetes and cancer.
Chapal N; Molina L; Molina F; Laplanche M; Pau B; Petit P
Fundam Clin Pharmacol; 2004 Aug; 18(4):413-22. PubMed ID: 15312147
[TBL] [Abstract][Full Text] [Related]
7. Location proteomics: a systems approach to subcellular location.
Murphy RF
Biochem Soc Trans; 2005 Jun; 33(Pt 3):535-8. PubMed ID: 15916558
[TBL] [Abstract][Full Text] [Related]
8. Drug target identification from protein dynamics using quantitative pathway analysis.
Good DM; Zubarev RA
J Proteome Res; 2011 May; 10(5):2679-83. PubMed ID: 21434696
[TBL] [Abstract][Full Text] [Related]
9. Dynamic proteomics reveals bimodal protein dynamics of cancer cells in response to HSP90 inhibitor.
Zimmer A; Amar-Farkash S; Danon T; Alon U
BMC Syst Biol; 2017 Mar; 11(1):33. PubMed ID: 28270142
[TBL] [Abstract][Full Text] [Related]
10. The metal-binding domain of IGFBP-3 selectively delivers therapeutic molecules into cancer cells.
Huq A; Singh B; Meeker T; Mascarenhas D
Anticancer Drugs; 2009 Jan; 20(1):21-31. PubMed ID: 19342998
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
12. Pro-apoptotic activities of novel synthetic quinones in human cancer cell lines.
Sagar S; Green IR
Cancer Lett; 2009 Nov; 285(1):23-7. PubMed ID: 19481864
[TBL] [Abstract][Full Text] [Related]
13. Freezing-assisted intracellular drug delivery to multidrug resistant cancer cells.
Teo KY; Han B
J Biomech Eng; 2009 Jul; 131(7):074513. PubMed ID: 19640149
[TBL] [Abstract][Full Text] [Related]
14. Campylobacter proteomics: guidelines, challenges and future perspectives.
Scott NE; Cordwell SJ
Expert Rev Proteomics; 2009 Feb; 6(1):61-74. PubMed ID: 19210127
[TBL] [Abstract][Full Text] [Related]
15. Differential expression patterns of SUMO proteins in HL-60 cancer cell lines support a role for sumoylation in the development of drug resistance.
Vigodner M; Weisburg JH; Shrivastava V; Marmor RA; Fathy J; Skop N
Cell Tissue Res; 2009 May; 336(2):277-86. PubMed ID: 19326147
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in aquatic plants: selection and utility.
Brain RA; Cedergreen N
Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
[TBL] [Abstract][Full Text] [Related]
17. Resistance to cytotoxic chemotherapy-induced apoptosis in side population cells of human oral squamous cell carcinoma cell line Ho-1-N-1.
Yajima T; Ochiai H; Uchiyama T; Takano N; Shibahara T; Azuma T
Int J Oncol; 2009 Aug; 35(2):273-80. PubMed ID: 19578740
[TBL] [Abstract][Full Text] [Related]
18. Cytoskeleton structure and dynamic behaviour: quick excursus from basic molecular mechanisms to some implications in cancer chemotherapy.
Alberti C
Eur Rev Med Pharmacol Sci; 2009; 13(1):13-21. PubMed ID: 19364082
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
Winquist RJ; Boucher DM; Wood M; Furey BF
Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
